We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Ichor Holdings
ICHR
$2.09B
| $2.11M | ﹤0.01% |
107,629
+76,257
| +243% | +$1.4M |
|
927
Koppers
KOP
$871M
| $2.1M | ﹤0.01% |
65,287
-3,163
| -5% | -$90.8K |
|
928
LKQ Corp
LKQ
$6.37B
| $2.09M | ﹤0.01% |
56,568
-480,308
| -89% | -$19.2M |
|
929
The Ensign Group
ENSG
$10.1B
| $2.08M | ﹤0.01% |
13,461
+906
| +7% | +$127K |
|
930
Halliburton
HAL
$29.8B
| $2.07M | ﹤0.01% |
101,563
+90,984
| +860% | +$1.91M |
|
931
Northern Oil and Gas
NOG
$2.72B
| $2.06M | ﹤0.01% |
72,683
+16,307
| +29% | +$439K |
|
932
RB Global
RBA
$15.8B
| $2.06M | ﹤0.01% |
19,394
+294
| +2% | +$30.1K |
|
933
Albemarle
ALB
$16.1B
| $2.06M | ﹤0.01% |
32,828
+32,311
| +6,250% | +$1.91M |
|
934
Murphy Oil
MUR
$5.09B
| $2.05M | ﹤0.01% |
91,113
+77,386
| +564% | +$1.73M |
|
935
Caterpillar
CAT
$368B
| $2.03M | ﹤0.01% |
5,233
-41,506
| -89% | -$13.8M |
|
936
Lear
LEA
$8.22B
| $2.03M | ﹤0.01% |
21,372
-4,273
| -17% | -$376K |
|
937
Shake Shack
SHAK
$2.82B
| $2.02M | ﹤0.01% |
14,351
+8,818
| +159% | +$960K |
|
938
Boyd Gaming
BYD
$5.79B
| $2.01M | ﹤0.01% |
25,660
-3,223
| -11% | -$230K |
|
|
TPH
939
DELISTED
Tri Pointe Homes
TPH
| $2M | ﹤0.01% |
62,709
+6,734
| +12% | +$207K |
|
940
Nu Skin
NUS
$232M
| $2M | ﹤0.01% |
250,585
-173,398
| -41% | -$1.22M |
|
941
Fortrea Holdings
FTRE
$1.8B
| $1.99M | ﹤0.01% |
+402,861
| New | +$2.17M |
|
942
Hertz
HTZ
$770M
| $1.99M | ﹤0.01% |
291,019
-16,939
| -6% | -$106K |
|
943
Crane NXT
CXT
$2.85B
| $1.97M | ﹤0.01% |
36,570
-7,746
| -17% | -$395K |
|
944
SCYNEXIS
SCYX
$54.3M
| $1.95M | ﹤0.01% |
361,875
| – | – |
|
945
Graphic Packaging
GPK
$3.39B
| $1.95M | ﹤0.01% |
92,413
-60,531
| -40% | -$1.4M |
|
946
Varex Imaging
VREX
$780M
| $1.95M | ﹤0.01% |
+224,503
| New | +$1.83M |
|
947
Nice
NICE
$6.34B
| $1.94M | ﹤0.01% |
11,500
| – | – |
|
948
i3 Verticals
IIIV
$296M
| $1.94M | ﹤0.01% |
70,587
+14,295
| +25% | +$358K |
|
949
WD-40
WDFC
$2.92B
| $1.94M | ﹤0.01% |
8,493
| – | – |
|
950
Caesars Entertainment
CZR
$6.04B
| $1.92M | ﹤0.01% |
67,680
-6,519
| -9% | -$177K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.